default author photo

Adam J. Schoenfeld

Memorial Sloan Kettering Cancer Center

New York, NY 10065

United States

  • Memorial Sloan Kettering Cancer Center

SCHOLARLY PAPERS

3

DOWNLOADS

161

TOTAL CITATIONS

1

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older with Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in Pd-L1 High (≥50%) Patients

Number of pages: 35 Posted: 03 Jan 2025
Adriana P. C. Barrichello, Arielle Elkrief, Biagio Ricciuti, Teja Ganta, Thomas U. Marron, Xinan Wang, William Lotter, James Lindsay, Valentina Santo, Alessio Cortellini, Bijaya Sharma, Kristen Felt, Kathleen Pfaff, Giuseppe Lamberti, Federica Pecci, Alessandro Di Federico, Maisam Makarem, Malini M. Gandhi, Tom Nguyen, Danielle Haradon, Victor R. Vaz, Bruce E. Johnson, Neha Debnath, Yinghong Wang, Andrew G. Kuang, Anwaar Saeed, Maluki Radford, Christine M. Lovly, Caroline A. Nebhan, David J. Pinato, Scott J. Rodig, Adam J. Schoenfeld, Mark M. Awad, Joao V. Alessi and Abdul Rafeh Naqash
Harvard University - Dana-Farber Cancer Institute, affiliation not provided to SSRN, Harvard University - Dana-Farber Cancer Institute, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Imperial College London, affiliation not provided to SSRN, affiliation not provided to SSRN, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, University of California, Los Angeles (UCLA), Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, affiliation not provided to SSRN, MD Anderson Cancer Center - Department of Gastroenterology, Hepatology and Nutrition, affiliation not provided to SSRN, University of Kansas - Cancer Center, University of Kansas - University of Kansas Medical Center, Vanderbilt University, Vanderbilt University - Medical Center, Imperial College London, Harvard University - Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Harvard University - Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute and University of Oklahoma - Stephenson Cancer Center
Downloads 87 (783,685)

Abstract:

Loading...

Non-Small Cell Lung Cancer, immunotherapy, pembrolizumab, Tumor microenvironment, Tumor immunophenotype, Older adults

2.

Pan-Cancer Analysis in the Real-World Setting Uncovers Immunogenomic Drivers of Acquired Resistance Post-Immunotherapy

Number of pages: 52 Posted: 30 Jul 2025
Mohamed Reda Keddar, Sebastian Carrasco Pro, Roy Rabbie, Zeynep Kalender Atak, Ana Camelo Stewart, Scott A. Hammond, Douglas C. Palmer, Ross Stewart, Kathleen Burke, Ben Sidders, Jessica Davies, Jonathan Dry, Inigo Martincorena, Sajan Khosla, Adam J. Schoenfeld, Martin L. Miller and Sneak Peek Administrator
AstraZeneca Pharmaceuticals - UK, Boehringer Ingelheim Pharmaceuticals Inc, AstraZeneca Pharmaceuticals - UK, Quotient Therapeutics Inc, AstraZeneca Pharmaceuticals - UK, AstraZeneca Pharmaceuticals - AstraZeneca R&D, AstraZeneca Pharmaceuticals - AstraZeneca R&D, AstraZeneca Pharmaceuticals - UK, Tempus AI, Inc., Biorelate Ltd, AstraZeneca Farmaceutica Spain SA, Tempus AI, Inc., Wellcome Sanger Institute, AstraZeneca Pharmaceuticals - UK, Memorial Sloan Kettering Cancer Center, AstraZeneca Pharmaceuticals - UK and Independent
Downloads 38 (1,236,159)

Abstract:

Loading...

cancer immunotherapy, acquired resistance, immunogenomics, real-world data

3.

Optimal Systemic Treatment and Real-World Clinical Application of Ctdna in Patients with Metastatic Her2-Mutant Lung Cancer

Number of pages: 15 Posted: 15 May 2024
Si-Yang Liu, Tatiana Erazo, Justin Jee, Andrea Arfe, Avantika Gupta, Luke Roy George Pike, Fernando C. Santini, Bobby Daly, Adam J. Schoenfeld, Jordan E. Eichholz, Kaylie Johnson, Andres Martinez, Jane Sui, Nadeem Riaz, Jason Chang, Soo-Ryum Yang, William Travis, Maria E. Arcila, Jiannan Guo, Eric Gagne, Karvita Garg, Frederick L. Baehner, Nancy Y. Lee, Alexander Drilon, Mark G. Kris, Howard I. Scher, Pedram Razavi, Daniel Gomez, David R. Jones, Charles M. Rudin, Sarat Chandarlapaty, James M. Isbell and Bob T. Li
Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Exact Sciences Corporation, Memorial Sloan Kettering Cancer Center - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center, Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Cancer Center
Downloads 36 (1,249,711)
Citation 1

Abstract:

Loading...

immunotherapy, Targeted Therapy, HER2 mutation, ctDNA, NSCLC